<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="in PBS at room temperature for 20Â min, or 95%" exact="ethanol" post="and 5% glacial acetic acid at âˆ’20Â Â°C for"/>
 <result pre="corresponding YFV proteins when the cells were fixed with 95%" exact="ethanol" post="and 5% glacial acetic acid (Fig. 2B). All these"/>
 <result pre="min and permeabilized with 1% Triton X-100 (A), or 95%" exact="ethanol" post="and 5% glacial acetic acid at âˆ’20Â Â°C for"/>
 <result pre="The cells were fixed with either 3.5% paraformaldehyde or 95%" exact="ethanol" post="and 5% glacial acetic acid as indicated in Fig."/>
 <result pre="cells were either mock treated (Act D-) or treated with" exact="Actinomycin D" post="(Act D+) for 2Â h followed by EU labelling"/>
 <result pre="in Fig. 7B, consistent with published in vitro antiviral data," exact="Sofosbuvir" post="inhibits YFV at EC50 of 8.82Â Î¼M and EC90"/>
 <result pre="of 32.4Â Î¼M (de Freitas et al., 2019). Combination of" exact="Sofosbuvir" post="and BDAA, resulted in significant synergistic effect of inhibiting"/>
 <result pre="and negative control wells. (B) Synergistic effect between BDAA and" exact="Sofosbuvir" post="identified using high-content imaging-based HTS assay. Huh-7Â cells were"/>
 <result pre="Infect. Dis.2220161859186027479749 de FreitasC.S.HigaL.M.SacramentoC.Q.FerreiraA.C.ReisP.A.DelvecchioR.MonteiroF.L.Barbosa-LimaG.James WestgarthH.VieiraY.R.MattosM.RochaN.HoelzL.V.B.LemeR.P.P.BastosM.M.RodriguesG.O.L.LopesC.E.M.Queiroz-JuniorC.M.LimaC.X.CostaV.V.TeixeiraM.M.BozzaF.A.BozzaP.T.BoechatN.TanuriA.SouzaT.M.L.Yellow fever virus is susceptible to" exact="sofosbuvir" post="both in vitro and in vivoPLoS Neglected Trop. Dis.132019e0007072"/>
</results>
